A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets ...

A study has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal type of brain cancer.

Researchers have identified a unique stem cell in the young brain capable of maturing into multiple cell types, potentially explaining the origins of autism and glioblastoma.

The discovery of a new type of stem cell in the brain could usher in better treatments for the deadliest brain tumor.

UCSF scientists have discovered a stem cell in the young brain that's capable of forming the cells found in tumors. The ...

CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...

A study published in Nature Genetics reveals new insights into how medulloblastoma, the most common malignant brain tumor of ...

A study published in Nature Genetics reveals new insights into how medulloblastoma, the most common malignant brain tumor of ...

A study co-led by UCLA scientists has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal ...

Michael Truskoski, 41, is more grateful than ever for every moment with his family. His daughters, 3 and 7 years old, have an idea that their dad is sick, but it is hard to understand that Daddy has ...